Reviewed 21 Jul 2026
Completeness Fair (22%)
Ki-67 Quantifier clinical
VMscope GmbHSupported by 3 papers
General Information
Product name
Company
Modality
Main task
Subspeciality
Organ/Specimen source
Not specified
Disease targeted
Not specified
Specimen type
Not specified
Staining
Stain subtype
Regulatory Information
Pathway:
In Vitro Diagnostic Directive (IVDD)
Class:
General IVD Devices
Not verified by Health AI Register
Scanner Brands Certified for Use (CE-IVD)
Not specified
Scanner Models Certified for Use (CE-IVD)
Not specified
Other certifications
Not specified
Evidence & Research
Peer-Reviewed Papers
Effects of pregnancy on breast cancer immunology: immune biomarker and TIL quantification
npj Breast Cancer · May 2025
On-treatment biopsies to predict response to neoadjuvant chemotherapy for breast cancer
Breast Cancer Research · Sep 2024
Standardized Ki67 Diagnostics Using Automated Scoring—Clinical Validation in the GeparTrio Breast Cancer Study
Clinical Cancer Research · Dec 2014
Technical Specifications
Patient population age
Not specified
Input
Not specified
Input format
Not specified
Output
Not specified
Output format
Not specified
Integration
Not specified
Deployment
Not specified
Trigger for analysis
Not specified
Processing time
Not specified
Population
Not specified
Viewer systems
Not specified
Market Presence
On market since
Not specified
AI Platforms
Resellers
Not specified
Countries present
Not specified
Paying clinical customers
Not specified
Research/test users
Not specified
Pricing Information
Pricing model
Not specified
Based on
Not specified
First published: Jul 30, 2025 | Last updated: Jul 21, 2026